메뉴 건너뛰기




Volumn 30, Issue 1, 2002, Pages 100-106

A phase II randomized, controlled trial of continuous hemofiltration in sepsis

Author keywords

Anaphylatoxins; Complement; Cytokines; Hemofiltration; Interleukin 10; Interleukin 6; Interleukin 8; Multiple organ failure; Septic shock; Tumor necrosis factor

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

EID: 0036154952     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200201000-00016     Document Type: Article
Times cited : (252)

References (17)
  • 2
  • 7
    • 0000557662 scopus 로고    scopus 로고
    • Evidence-based analysis of the role of hemofiltration in sepsis and multiorgan dysfunction syndrome
    • (1997) Curr Opin Crit Care , vol.3 , pp. 434-441
    • Schetz, M.1
  • 8
    • 0026874127 scopus 로고
    • Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
    • (1992) Crit Care Med , vol.20 , pp. 864-874


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.